Evidence map›Paper›PMID 40729545›Full record

ArticleAdvanced biology2025

Activation of NF-κB Signaling by Optogenetic Clustering of IKKα and β.

Alexandra Anna Maria Fischer, Markus Michael Kramer, Miguel Baños, Merlin Moritz Grimm, Manfred Fliegauf, Bodo Grimbacher, Gerald Radziwill, Sven Rahmann, Wilfried Weber

Abstract read
In one paragraph

Article in Advanced biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandra Anna Maria FischerSignalling Research Centers BIOSS and CIBSS, University of Freiburg, Schänzlestr. 18, 79104, Freiburg, Germany.
Markus Michael KramerSignalling Research Centers BIOSS and CIBSS, University of Freiburg, Schänzlestr. 18, 79104, Freiburg, Germany.
Miguel BañosINM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrücken, Germany.
Merlin Moritz GrimmSignalling Research Centers BIOSS and CIBSS, University of Freiburg, Schänzlestr. 18, 79104, Freiburg, Germany.
Manfred FliegaufInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Breisacherstr. 115, 79106, Freiburg, Germany.
Bodo GrimbacherInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Breisacherstr. 115, 79106, Freiburg, Germany.
Gerald RadziwillSignalling Research Centers BIOSS and CIBSS, University of Freiburg, Schänzlestr. 18, 79104, Freiburg, Germany.
Sven RahmannAlgorithmic Bioinformatics, Center for Bioinformatics Saar and Saarland University, Saarland Informatics Campus E2.1, 66123, Saarbrücken, Germany.
Wilfried WeberINM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrücken, Germany.ORCID 0000-0003-4340-4446

Funding

Deutsche Forschungsgemeinschaft GSC-4Excellence Initiative of the German Federal and State Governments - BIOSS EXC-294Germany's Excellence Strategy - CIBSS 390 939 984Germany's Excellence Strategy - CIBSS EXC-2189HORIZON EUROPE European Research Council ERC-AdG-101053857-STEADYMinistry for Science, Research and Arts of the State of Baden-Württemberg as well as by the European Union 101 053 857
6 · The paper itself

Abstract

Molecular optogenetics allows the control of molecular signaling pathways in response to light. This enables the analysis of the kinetics of signal activation and propagation in a spatially and temporally resolved manner. A key strategy for such control is the light-inducible clustering of signaling molecules, which leads to their activation and subsequent downstream signaling. In this work, an optogenetic approach is developed for inducing graded clustering of different proteins that are fused to eGFP, a widely used protein tag. To this aim, an eGFP-specific nanobody is fused to Cryptochrome 2 variants engineered for different orders of cluster formation. This is exemplified by clustering eGFP-IKKα and eGFP-IKKβ, thereby achieving potent and reversible activation of NF-κB signaling. It is demonstrated that this approach can activate downstream signaling via the endogenous NF-κB pathway and is thereby capable of activating both an NF-κB-responsive reporter construct as well as endogenous NF-κB-responsive target genes as analyzed by RNA sequencing. The generic design of this system is likely transferable to other signaling pathways to analyze the kinetics of signal activation and propagation.

Indexed as

I-kappa B KinaseNF-kappa BOptogeneticsSignal TransductionCryptochromesGreen Fluorescent ProteinsHEK293 CellsHumansCRY2 protein, humanCryptochromesenhanced green fluorescent proteinGreen Fluorescent ProteinsI-kappa B KinaseIKBKB protein, humanNF-kappa BNF‐κB signalingoligomerizationoptogeneticsphase separationsynthetic biology

Identifiers

PMID40729545
PMCPMC12447120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.